BCAB Competitors & Alternatives
Compare Bioatla Inc with similar stocks in the same industry
Biotechnology
BCAB
Main Stock$1.74
Tradestie Score
39
Market Cap
$39.57M
Revenue Growth
0.3%
Analyst Upside
+476.4%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.95
|
$170.45M | - | 57 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$7.53
|
$158.43M | - | 50 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.72
|
$154.27M | - | 67 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$3.14
|
$153.02M | - | 70 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.07
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.84
|
$114.01M | - | 45 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$25.31
|
$110.20M | - | 65 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.30
|
$96.93M | - | 62 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.89
|
$84.52M | - | 57 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.23
|
$67.94M | - | 47 | Compare |
More BCAB Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
232 stocks in this industry